CHROMOSOME ANALYSIS with Y-DNA MICRODELETION ANALYSIS
CYSTIC FIBROSIS PANEL for CBAVD
(Congenital Bilateral Absence of the Vas Deferens)
The development of assisted reproductive technologies, specifically intracytoplasmic sperm injection (ICSI), now enables many infertile men to have children. Before undergoing ICSI, it is important to discover the cause of infertility. A significant proportion of men with infertility may have a genetic alteration causing their infertility. This fact is significant because these men are at increased risk for having recurrent miscarriages with their partner, children with birth defects and learning disabilities, and male offspring with infertility. Three main genetic causes for male infertility characterized by severe oligospermia (low sperm production) or azoospermia (no sperm production) are: 1. chromosome abnormalities, 2. Y-chromosome microdeletions, or 3. mutations (changes within the cystic fibrosis gene.
1. CHROMOSOME ABNORMALITIES
Approximately 5-10% of men with oligospermia and 10-15% of men with azoospermia carry a chromosome abnormality, most commonly of the sex chromosomes. Chromosomes are units of genetic information in the cells of the body. Each cell should contain 46 chromosomes, arranged into 23 pairs. The last pair of chromosomes is the sex chromosomes, X and Y. Males should have an X and a Y (46,XY), while females should have two Xs (46,XX).
The most common chromosome abnormality associated with male infertility is Klinefelter syndrome, in which males carry an extra X chromosome (47,XXY). Klinefelter syndrome is characterized by an increased chance for learning disabilities, minor physical differences, and infertility. Most men with Klinefelter syndrome go undetected until experiencing difficulty with their partner concerning children, and an evaluation for infertility is performed. With the assistance of ICSI, men with Klinefelter syndrome are often able to have children. Although these men can have healthy children, there is also an increased chance to have a child with a sex chromosome abnormality.
Other chromosome abnormalities may also cause infertility in the otherwise healthy male. An example of a structural chromosome abnormality is a translocation, in which pieces of chromosomes from two different pairs are switched. Men carrying these types of chromosome abnormalities are at an increased risk for their partner having miscarriages and children born with birth defects and mental retardation. Carriers can also have healthy offspring with normal chromosome or a normal offspring that are carriers like the parent.
A chromosome analysis should be routinely offered to all men with infertility before proceeding with ICSI.
2. Y-CHROMOSOME MICRODELETIONS
About 10-18% of men requesting ICSI who have severe oligospermia or azoospermia have small deletions (microdeletions) within one of the AZF (azoospermia factor) regions or certain other regions (AMELY, SRY, ZFY) of their Y chromosomes. Several genes on the Y chromosome are required for normal spermatogenesis (the process of making the sperm). The absence of one or more of these genes causes infertility. Men with Y microdeletions who undergo ICSI are at risk for producing sons with the same deletions. These sons could also experience infertility. Y chromosome microdeletion analysis should routinely be offered to all men with severe oligospermia or azoospermia.
CYSTIC FIBROSIS GENE MUTATIONS
Cystic Fibrosis (CF) is a genetic disorder typically characterized by complications of the lung and pancreas. CF is inherited as an autosomal recessive disorder. Autosomal means the abnormal gene is not on a sex chromosome. Recessive means the effect of the gene would only be seen when a baby inherits an abnormal recessive gene from both parents.
Certain mutations within the cystic fibrosis gene are known to cause congenital bilateral absence of the vas deferens (CBAVD); congenital unilateral absence of the vas deferens (CUAVD), without manifestations in the lung or pancreas; or obstructed vas deferens. Abnormalities of the vas deferens cause oligospermia and azoospermia, which consequently results in infertility in men carrying the associated mutations. Approximately 40% of men with CUAVD and 50-80% of men with CBAVD have at least one mutation within the CF gene. A common CF mutation associated with CBAVD is called the 5T variant. Men with CBAVD or CUAVD in addition to unilateral renal agenesis (absence of a kidney) are not at increased risk for carrying CF mutations.
Men with CBAVD or CUAVD who carry CF mutation(s) are at an increased risk for having children with infertility, or classical Cystic Fibrosis if the mother is also a carrier of a CF mutation. All men with CBAVD and CUAVD should routinely be offered CF testing before undergoing ICSI.
WHO SHOULD BE OFFERED CHROMOSOME ANALYSIS, Y-CHROMOSOME MICRODELETION TESTING, and/or CF GENE TESTING?
All males with severe oligospermia and azoospermia should be offered chromosome analysis and DNA analysis for Y chromosome microdeletions before proceeding with ICSI. Men with CBAVD, CUAVD, or obstructive azoospermia should routinely be offered CF testing as well.
TESTING SERVICES:
Chromosome analysis - Specimen: 10 ml whole blood in a green top Na Heparin tube. Specimen: 10 ml whole blood in a green top EDTA tube. Results available: 7 days
Y-Chromosome Microdeletion Testing - Specimen: 10 ml whole blood in a lavender top EDTA tube. Results Available: 2-3 weeks
Cystic Fibrosis Gene Testing - Specimen: 10 ml whole blood in a lavender top EDTA tube. Results Available: 1 week
HOW CAN TESTING BE ARRANGED?
Physicians or healthcare providers may contact one of our Centers for consultations. Blood specimens may be sent by a physician or healthcare provider or drawn at GeneCare if testing is recommended.
Couples experiencing male factor infertility who are interested in pursuing assisted reproduction are encouraged to discuss genetic testing with their physicians or healthcare providers and to consider having genetic counseling at GeneCare. During counseling, a detailed family history will be reviewed and appropriate testing determined for each individual situation.
SPECIMEN COLLECTION:
Call GeneCare at (800) 277- 4363 or (866) 881-2592 to discuss clinical indications, current testing, informed consent, fees, and payment method.
Complete Consent Forms and Laboratory Request. Enclose family history.
Label each specimen tube with patient name, birth date, and collection date.
SPECIMEN TRANSPORT:
Enclose Laboratory Request / Consent Forms
SHIP AT ROOM TEMPERATURE in our kit to:
GeneCare Medical Genetics Center
120 Conner Drive, Suite 201, Chapel Hill, NC 27514-7085OR
GeneCare Wilson Genetics Laboratory
4701 Randolph Road, Suite G9, Rockville, MD 20852
REFERENCES:
Johnson, M. D. Genetic risks of intracytoplasmic sperm injection in the treatment of male infertility: recommendations for genetic counseling and screening.
Fertility and Sterility 1998; 70: 397-411.
Kim, E. D., Bischoff, F. Z., Lipshultz, L. I., and Lamb, D. J. Genetic concerns for the subfertile male in the era if ICSI. Prenat. Diagn. 1998; 18: 1349-1365.
Meschede, D., and Horst, J. Genetic counselling for infertile male patients. Int. J. of Andrology 1997; 20(3): 20-30.
Schlegel, P. N. and Girardi, S. K. Clinical review 87: In vitro fertilization for male factor infertility. J Clin Endocrinol Metab 1997; 82(3): 709-16.
[About GeneCare] [Paternity
Testing] [Physician Info]
[Patient Info]
[Conferences] [What's
New?] [Awards]
[QuadInhibin][Employment
Opportunities] [Contact Us] [Purchase Books]
[Privacy
Statement]
[Site Index]
Last modified: May 25, 2004 04:26 PM
© 2003 GeneCare, All Rights Reserved.